Yes, treatment for CML should continue indefinitely

Research output: Contribution to journal › Article › peer-review

Original language	English (US)
Pages (from-to)	489-492
Number of pages	4
Journal	Clinical advances in hematology & oncology : H&O
Volume	15
Issue number	6
State	Published - Jun 1 2017

ASJC Scopus subject areas

@article{173c935a10954d7695cb6bdc49b37f79,

title = "Yes, treatment for CML should continue indefinitely",

author = "Short, {Nicholas J.} and Elias Jabbour",

year = "2017",

month = jun,

day = "1",

language = "English (US)",

volume = "15",

pages = "489--492",

journal = "Clinical advances in hematology & oncology : H&O",

issn = "1543-0790",

publisher = "Millennium Medical Publishing, Inc.",

number = "6",

}

TY - JOUR

T1 - Yes, treatment for CML should continue indefinitely

AU - Short, Nicholas J.

AU - Jabbour, Elias

PY - 2017/6/1

Y1 - 2017/6/1

UR - http://www.scopus.com/inward/record.url?scp=85054453508&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85054453508&partnerID=8YFLogxK

M3 - Article

C2 - 28749909

AN - SCOPUS:85054453508

SN - 1543-0790

VL - 15

SP - 489

EP - 492

JO - Clinical advances in hematology & oncology : H&O

JF - Clinical advances in hematology & oncology : H&O

IS - 6

ER -